Crossref
Molecular Docking of Pharmaceutical Cocrystal As a Ligand: Do We Need to Rethink?
Crystal Growth & Design · 04.01.2023 · 23 (1) · 1-5
DOI: 10.1021/acs.cgd.2c01379 ↗Kurz gefasst
Fachartikel in der Zeitschrift Crystal Growth & Design, online erschienen am 19.12.2022. Verfasst von Parag Roy und 2 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Roy, P., Pandey, N., & Ghosh, A. (2023). Molecular Docking of Pharmaceutical Cocrystal As a Ligand: Do We Need to Rethink?. Crystal Growth & Design, 23(1), 1-5. https://doi.org/10.1021/acs.cgd.2c01379
Vancouver
Roy P, Pandey N, Ghosh A. Molecular Docking of Pharmaceutical Cocrystal As a Ligand: Do We Need to Rethink?. Crystal Growth & Design. 2023;23(1):1-5. doi:10.1021/acs.cgd.2c01379
BibTeX
@article{Roy2023,
author = {Roy, Parag and Pandey, Noopur and Ghosh, Animesh},
title = {Molecular Docking of Pharmaceutical Cocrystal As a Ligand: Do We Need to Rethink?},
journal = {Crystal Growth & Design},
year = {2023},
volume = {23},
number = {1},
pages = {1--5},
doi = {10.1021/acs.cgd.2c01379}
}
EUVIMED